EDIT | Editas MedicineNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$2.72
+$0.12 (+4.62%)

Editas Medicine (EDIT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since May 2026, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits between the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 4 Nov 16:00 ET

Price
between the two $2.72 vs 50 $2.73 / 200 $2.69
Projection
Death cross projected in 4 bars
Test
No active test
Last cross
Golden cross 5 May 2026 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $2.67 vs 50 $2.60 / 200 $4.76
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 13 Jun 2022 ยท projected 19 bars out

4-hour as of 4 Nov 13:30 ET

Price
between the two $2.71 vs 50 $2.61 / 200 $2.83
Projection
No cross projected
Test
No active test
Last cross
Death cross 28 Sep 2026 ยท projected 30 bars out

Cross history

29
crosses on record since 2017
14 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 Sep 2026Death4-hour30 bars outNot tested
4 Sep 2026Golden4-hour22 bars outโ€”
12 Aug 2026Death4-hour27 bars out6 bar cross test
5 May 2026Golden steepdaily26 bars outNot tested
27 Mar 2026Golden4-hour20 bars out4 bar cross test

About EDIT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$6.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.